Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Magnetic Resonance Spectroscopy 26 pembrolizumab 17 Radiotherapy 17 Specimen Handling 16 Nivolumab 15 Cyclophosphamide 14 Temozolomide 11 Biopsy 11 fludarabine 9 Fluorodeoxyglucose F18 9 X-Rays 8 Etoposide 7 Bevacizumab 7 Standard of Care 6 Radiation 6 Paclitaxel 6 Dexamethasone 6 Cisplatin 6 Carboplatin 6 Surgical Procedures, Operative 5 Ipilimumab 5 Doxorubicin 5 Aspirin 5 venetoclax 4 fluciclovine F-18 4 atezolizumab 4 abemaciclib 4 Vincristine 4 Rituximab 4 Radiosurgery 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Atovaquone × 1 year × Clear all

NCT03568994 2026-01-27

ATACC AML

Baylor College of Medicine

Phase EARLY_PHASE1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡